Stock BRTX BIORESTORATIVE THERAPIES, INC.
Add to a list
To use this feature you must be a member
Log inSign up

News BioRestorative Therapies, Inc.

Equities

BRTX

US0906556065

Market Closed - Nasdaq
Other stock markets
 16:00:00 2024-06-26 EDT 		5-day change 1st Jan Change
2.02 USD -4.72% Intraday chart for BioRestorative Therapies, Inc. -0.49% +16.10%
06-13 Top Midday Gainers MT
06-13 Sector Update: Health Care Stocks Mixed Pre-Bell Thursday MT

Summary

Search
See the results
Unlock all the news: Be the first to know and act before the market!
100% Free Registration
BioRestorative Therapies Regains Compliance with Nasdaq Listing Rule 5250(1), Reports First Quarter 2024 Financial Results
AQ
BioRestorative Therapies Regains Compliance with Nasdaq Listing Rule 5250(c)(1); Reports First Quarter 2024 Financial Results
AQ
Top Midday Gainers
MT
Sector Update: Health Care Stocks Mixed Pre-Bell Thursday
MT
Sector Update: Health Care
MT
BioRestorative Therapies in Licensing Talks for Metabolic Disease Program -- Shares Rise Pre-Bell
MT
Exchange-Traded Funds Edge Higher, Equity Futures Mixed Pre-Bell Thursday Ahead of Key Economic Data
MT
BioRestorative Therapies in Substantive Discussions for Potential License Agreement for ThermoStem® Metabolic Disease Program
AQ
BioRestorative Therapies, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024
CI
BioRestorative Therapies, Inc. to attend the Jefferies 2024 Healthcare Conference
AQ
BioRestorative Therapies Announces Receipt of Nasdaq Non-Compliance Notice
AQ
BioRestorative Therapies : Non-Reliance on Previously Issued Financial Report - Form 8-K
PU
BioRestorative Announces Signing a Five-Year Exclusive Supply Agreement with Cartessa Aesthetics, LLC
CI
BioRestorative Therapies Provides First Quarter 2024 Business Update
AQ
BioRestorative Therapies Enhances Preclinical Metabolic Program with a Novel Exosome-Based Biologic Targeting Obesity
AQ
BioRestorative Therapies, Inc. Enhances Preclinical Metabolic Program with A Novel Exosome-Based Biologic Targeting Obesity
CI
BioRestorative Therapies to Report First Quarter 2024 Financial Results and Host Conference Call on May 14, 2024
AQ
BioRestorative Therapies Announces Transformative Commercial Agreement with Cartessa, a Global Leader in Medical Aesthetics Technology
AQ
BioRestorative Therapies, Inc. Announces Transformative Commercial Agreement with Cartessa Aesthetics, LLC
CI
BioRestorative Therapies Shares Rise 17% After FDA Clears Phase 2 Study Protocol Amendment
DJ
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. BRTX Stock
  4. News BioRestorative Therapies, Inc.